Federico Grossi
2018
In 2018, Federico Grossi earned a total compensation of $2.8M as Chief Medical Officer at Apellis Pharmaceuticals.
Compensation breakdown
| Bonus | $153,125 |
|---|---|
| Option Awards | $2,234,000 |
| Salary | $341,391 |
| Other | $30,963 |
| Total | $2,759,478 |
Grossi received $2.2M in option awards, accounting for 81% of the total pay in 2018.
Grossi also received $153.1K in bonus, $341.4K in salary and $31K in other compensation.
Rankings
In 2018, Federico Grossi's compensation ranked 4,235th out of 14,244 executives tracked by ExecPay. In other words, Grossi earned more than 70.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,235 out of 14,244 | 70th |
Division Manufacturing | 1,570 out of 5,765 | 73rd |
Major group Chemicals And Allied Products | 561 out of 2,128 | 74th |
Industry group Drugs | 470 out of 1,817 | 74th |
Industry Pharmaceutical Preparations | 363 out of 1,391 | 74th |
Source: SEC filing on April 30, 2019.
Grossi's colleagues
We found four more compensation records of executives who worked with Federico Grossi at Apellis Pharmaceuticals in 2018.